Evidence map›Paper›PMID 28611089›Full record

Trial reportBMJ open2017

Protocol for a randomised controlled trial evaluating the effects of providing essential medicines at no charge: the Carefully seLected and Easily Accessible at No Charge Medicines (CLEAN Meds) trial.

Nav Persaud, Taehoon Lee, Haroon Ahmad, Winny Li, Michael Sergio Taglione, Yathavan Rajakulasingam, Norman Umali, Andrew Boozary, Richard H Glazier, Tara Gomes and 14 more

Registry-linked trialAbstract readMulticenter StudyRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02744963 (Carefully seLected and Easily Accessible at No Charge Medications), which is not on this map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02744963 naunknown statusnot on this map

Carefully seLected and Easily Accessible at No Charge Medications

TypeinterventionalSponsorUnity Health TorontoRan2016 to 2020Enrolled784ConditionsMedication Adherence, Inappropriate Prescribing, Diabetes, HypertensionArmsFree and convenient medicine access
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Trial
  4. Article
  5. Community members co-designing a trial of medication access.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2018
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Nav PersaudDepartment of Family and Community Medicine, St Michael's Hospital, Toronto, Canada.
Taehoon LeeLi Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
Haroon AhmadDepartment of Medicine, McMaster University, Hamilton, Ontario, Canada.
Winny LiDepartment of Medicine, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.
Michael Sergio TaglioneDepartment of Medicine, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.
Yathavan RajakulasingamLi Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
Norman UmaliLi Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
Andrew BoozaryDepartment of Family and Community Medicine, University of Toronto, Toronto, Ontario, Canada.
Richard H GlazierDepartment of Family and Community Medicine, St Michael's Hospital, Toronto, Canada.
Tara GomesDepartment of Family and Community Medicine, St Michael's Hospital, Toronto, Canada.
Stephen W HwangLi Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
Peter JüniDepartment of Medicine, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.
Michael LawCentre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, British Columbia, Canada.
Muhammad M MamdaniLi Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
Braden MannsDepartment of Community Health Science, Cumming School of Medicine, University of Calgary, Calgary, Canada.
Danielle MartinDepartment of Family and Community Medicine, St Michael's Hospital, Toronto, Canada.
Steve MorganCentre for Health Services and Policy Research, University of British Columbia, Vancouver, Canada.ORCID 0000-0002-7529-0028
Paul OhToronto Rehabilitation Institute, University Health Network, Toronto, Canada.
Andrew David PintoDepartment of Family and Community Medicine, St Michael's Hospital, Toronto, Canada.ORCID 0000-0003-1841-9347
Baiju R ShahDepartment of Medicine, University of Toronto Faculty of Medicine, Toronto, Ontario, Canada.
Frank M SullivanInstitute for Clinical Evaluative Sciences, Toronto, Canada.
Kevin E ThorpeLi Ka Shing Knowledge Institute, St Michael's Hospital, Toronto, Ontario, Canada.
Karen TuDepartment of Family and Community Medicine, St Michael's Hospital, Toronto, Canada.
Andreas LaupacisDepartment of Family and Community Medicine, St Michael's Hospital, Toronto, Canada.

Funding

CIHR
6 · The paper itself

Abstract

introductionCost-related non-adherence to medicines is common in low-income, middle-income and high-income countries such as Canada. Medicine non-adherence is associated with poor health outcomes and increased mortality. This randomised trial will test the impact of a carefully selected list of essential medicines at no charge (compared with usual medicine access) in primary care patients reporting cost-related non-adherence. METHODS AND ANALYSIS: This is an open-label, parallel two-arm, superiority, individually randomised controlled trial conducted in three primary care sites (one urban, two rural) in Ontario, Canada, that was codesigned by a community guidance panel. Adult patients (≥18 years) who report cost-related non-adherence to medicines are eligible to participate in the study. Participants will be randomised to receive free and convenient access to a carefully selected list of 125 essential medicines (based on the WHO's Model List of Essential Medicines) or usual means of medicine access. Care for patients in both groups will otherwise be unchanged. The primary outcome of this trial is adherence to appropriately prescribed medicines. Secondary outcomes include medicine adherence, appropriate prescribing, blood pressure, haemoglobin A1c, low-density lipoprotein cholesterol, patient-oriented outcomes and healthcare costs. All participants will be followed for at least 12 months. ETHICS AND DISSEMINATION: Ethics approval was obtained in all three participating sites. Results of the main trial and secondary outcomes will be submitted for publication in a peer-reviewed journal and discussed with members of the public and decision makers. TRIAL REGISTRATION NUMBER: NCT02744963.

Indexed as

Drug MonitoringAdolescentAdultAgedDrug CostsDrugs, EssentialFemaleHealth Care CostsHumansLogistic ModelsMaleMiddle AgedOntarioPrimary Health CareQuality of LifeResearch DesignDrugs, Essentialappropriate prescribingessential medicinesmedicine adherencemedicine costspatient-oriented outcomesrandomized controlled trial

Identifiers

PMID28611089
PMCPMC5623428

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.